Literature DB >> 9874469

A longitudinal magnetic resonance imaging study of the brain in survivors in childhood acute lymphoblastic leukemia.

A H Harila-Saari1, E L Pääkkö, L K Vainionpää, J Pyhtinen, B M Lanning.   

Abstract

BACKGROUND: The objective of this study was to evaluate changes in magnetic resonance imaging (MRI) of the brain in children with acute lymphoblastic leukemia (ALL) during the first 5 years after the cessation of therapy and to correlate MRI abnormalities with neuropsychologic outcome.
METHODS: Thirty-two children with ALL were studied at the end of treatment and 5 years later by brain MRI and the results were compared with the neuropsychologic findings. Fifteen patients had received chemotherapy alone and 17 had received chemotherapy plus cranial radiation.
RESULTS: MRI of the brain was abnormal in 6 of 30 patients at the end of treatment and in 8 of 32 patients 5 years later. White matter changes (WMC) were found in 3 patients at the end of treatment and in 4 patients 5 years later. Two patients had developed new mild changes, whereas in one case WMC had normalized during the follow-up. Two patients had old hemorrhages or calcifications at each examination, with some improvement after follow-up, although one case revealed a new calcification or hemorrhage. Signs of cortical atrophy were observed in five patients at both evaluations. The patients with abnormal MRI findings did not differ significantly in their performance in the neuropsychologic tests from the patients with normal MRI findings, but the two patients with persistent WMC had a depression of verbal functions.
CONCLUSIONS: Abnormalities in brain MRI were infrequent at the end of treatment for childhood ALL and 5 years later. They did not appear to correlate significantly with neuropsychologic outcome. Brain MRI is not very informative as a routine follow-up method during the first 5 years after treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9874469

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Reduced frontal white matter volume in long-term childhood leukemia survivors: a voxel-based morphometry study.

Authors:  M E Carey; M W Haut; S L Reminger; J J Hutter; R Theilmann; K L Kaemingk
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

Review 2.  Neurodevelopmental consequences of pediatric cancer and its treatment: applying an early adversity framework to understanding cognitive, behavioral, and emotional outcomes.

Authors:  Hilary A Marusak; Allesandra S Iadipaolo; Felicity W Harper; Farrah Elrahal; Jeffrey W Taub; Elimelech Goldberg; Christine A Rabinak
Journal:  Neuropsychol Rev       Date:  2017-12-22       Impact factor: 7.444

3.  Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study.

Authors:  Pek-Lan Khong; Dora L W Kwong; Godfrey C F Chan; Jonathan S T Sham; Fu-Luk Chan; Gaik-Cheng Ooi
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

4.  Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia.

Authors:  W E Reddick; J O Glass; D P Johnson; F H Laningham; C-H Pui
Journal:  AJNR Am J Neuroradiol       Date:  2009-07-30       Impact factor: 3.825

5.  MR imaging of the brain in patients cured of acute lymphoblastic leukemia--the value of gradient echo imaging.

Authors:  M S M Chan; D J Roebuck; M-P Yuen; C-K Li; Y-L Chan
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

6.  Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only.

Authors:  G Elisabeth Lofstad; Trude Reinfjell; Knut Hestad; Trond H Diseth
Journal:  Acta Paediatr       Date:  2008-09-30       Impact factor: 2.299

7.  Brain Microstructural Changes Associated With Neurocognitive Outcome in Intracranial Germ Cell Tumor Survivors.

Authors:  Winnie Wan Yee Tso; Edward Sai Kam Hui; Tatia Mei Chun Lee; Anthony Pak Yin Liu; Patrick Ip; Vince Vardhanabhuti; Kevin King Fai Cheng; Daniel Yee Tak Fong; Dorita Hue Fung Chang; Frederick Ka Wing Ho; Ka Man Yip; Dennis Tak Loi Ku; Daniel Ka Leung Cheuk; Chung Wing Luk; Ming Kong Shing; Lok Kan Leung; Pek Lan Khong; Godfrey Chi-Fung Chan
Journal:  Front Oncol       Date:  2021-05-26       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.